Logo image of ITRM

ITERUM THERAPEUTICS PLC (ITRM) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:ITRM - IE000TTOOBX0 - Common Stock

0.4609 USD
+0.01 (+1.74%)
Last: 12/10/2025, 4:10:54 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to ITRM. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 5.61. This target is 1117.18% above the current price.
ITRM was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ITRM.
In the previous month the buy percentage consensus was at a similar level.
ITRM was analyzed by 8 analysts. More opinions would make the average more meaningful.
ITRM Historical Analyst RatingsITRM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -89 -81 -73 -65 -57 -49 -41 -33 -25 -17 -9 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.462.025.615.619.45 - 338.27% 1,117.18% 1,117.18% 1,950.34%
ITRM Current Analyst RatingITRM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2024-09-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-15 HC Wainwright & Co. Maintains Buy -> Buy
2024-06-21 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-31 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-30 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-02-07 HC Wainwright & Co. Upgrade Neutral -> Buy
2021-07-27 Gabelli & Co. Upgrade Sell -> Hold
2021-07-26 HC Wainwright & Co. Downgrade Buy -> Neutral
2021-05-28 Gabelli & Co. Upgrade Sell -> Hold
2021-03-15 HC Wainwright & Co. Upgrade Neutral -> Buy

ITERUM THERAPEUTICS PLC / ITRM FAQ

What is the average price target for ITERUM THERAPEUTICS PLC (ITRM) stock?

8 analysts have analysed ITRM and the average price target is 5.61 USD. This implies a price increase of 1117.18% is expected in the next year compared to the current price of 0.4609.


How do analysts rate ITERUM THERAPEUTICS PLC (ITRM)?

The consensus rating for ITERUM THERAPEUTICS PLC (ITRM) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed ITERUM THERAPEUTICS PLC (ITRM)?

The number of analysts covering ITERUM THERAPEUTICS PLC (ITRM) is 8.